Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update reports that Ninerafaxstat is being studied for efficacy and safety in symptomatic non-obstructive hypertrophic cardiomyopathy a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-obstructive Hypertrophic Cardiomyopathy

Drugs mentioned

• Ninerafaxstat

Snippet

Sponsor: Imbria Pharmaceuticals, Inc. | Conditions: Non-obstructive Hypertrophic Cardiomyopathy | Phase 2 | Status: RECRUITING